T.Man Pharmaceutical PCL (BKK:TMAN)
Thailand · Delayed Price · Currency is THB 10.80
-0.20 (-1.82%)
At close: Aug 10, 2026
T.Man Pharmaceutical PCL Balance Sheet
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 562.06 | 399.31 | 348.39 | 348.04 | 307.17 | 22.19 |
Short-Term Investments | 353.68 | 352.3 | 450 | - | - | - |
Cash & Short-Term Investments | 915.74 | 751.62 | 798.39 | 348.04 | 307.17 | 22.19 |
Cash Growth | 115.42% | -5.86% | 129.40% | 13.30% | 1284.31% | -66.83% |
Accounts Receivable | 761.38 | 848.11 | 596.4 | 577.79 | 507.27 | 256.08 |
Other Receivables | 144.41 | 189.97 | 20.57 | 38.75 | 21.37 | 23.94 |
Receivables | 905.79 | 1,038 | 616.97 | 616.54 | 528.64 | 280.02 |
Inventory | 634.71 | 612.66 | 541.45 | 481.82 | 357.96 | 308.9 |
Other Current Assets | 3.45 | 3.15 | 3.51 | 4.99 | 32.2 | 4.21 |
Total Current Assets | 2,460 | 2,406 | 1,960 | 1,451 | 1,226 | 615.32 |
Property, Plant & Equipment | 1,230 | 1,204 | 1,143 | 1,048 | 930.41 | 742.63 |
Long-Term Investments | - | - | 200 | - | - | - |
Other Intangible Assets | 48.75 | 45.15 | 33.84 | 25.69 | 12.56 | 1.23 |
Long-Term Deferred Tax Assets | 44.61 | 45.24 | 34.25 | 38.89 | 40.69 | - |
Other Long-Term Assets | 83.4 | 83.71 | 84 | 63.18 | 68.24 | 199.02 |
Total Assets | 3,867 | 3,784 | 3,456 | 2,627 | 2,278 | 1,558 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 476.6 | 507.62 | 380.62 | 331.91 | 333.08 | 192.3 |
Short-Term Debt | 850 | 875 | 1,080 | 503.43 | 535 | 614.57 |
Current Portion of Long-Term Debt | - | - | - | 33.08 | 22 | 16.01 |
Current Portion of Leases | 5.94 | 5.17 | 5.66 | 7.08 | 4.55 | 3.01 |
Current Income Taxes Payable | 74.2 | 54.74 | 27.53 | 22.63 | 110.2 | 11.34 |
Current Unearned Revenue | 103.06 | 100.68 | 72.01 | 100.29 | 73.8 | - |
Other Current Liabilities | 9.54 | 10.09 | 10.27 | 23.98 | 20.46 | 59.06 |
Total Current Liabilities | 1,519 | 1,553 | 1,576 | 1,022 | 1,099 | 896.29 |
Long-Term Debt | - | - | - | - | 33.08 | 8.33 |
Long-Term Leases | 64.34 | 63.28 | 64.95 | 47.89 | 44.36 | 28.28 |
Pension & Post-Retirement Benefits | 50.35 | 49.02 | 44.09 | 35.18 | 32.13 | 28.21 |
Other Long-Term Liabilities | 1.18 | 1.1 | 0.58 | 2.39 | 26.93 | 25.89 |
Total Liabilities | 1,635 | 1,667 | 1,686 | 1,108 | 1,236 | 987 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 300 | 300 | 300 | 246.43 | 187.3 | 187.3 |
Additional Paid-In Capital | 1,394 | 1,394 | 1,394 | 305.88 | 305.88 | 305.88 |
Retained Earnings | 789.52 | 674.88 | 327.82 | 993.46 | 575.48 | 103.91 |
Comprehensive Income & Other | -251.78 | -251.78 | -251.78 | -26.37 | -26.37 | -24.95 |
Total Common Equity | 2,232 | 2,117 | 1,770 | 1,519 | 1,042 | 572.14 |
Minority Interest | - | 0 | -0 | 0 | 0 | -0.93 |
Shareholders' Equity | 2,232 | 2,117 | 1,770 | 1,519 | 1,042 | 571.21 |
Total Liabilities & Equity | 3,867 | 3,784 | 3,456 | 2,627 | 2,278 | 1,558 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 920.28 | 943.46 | 1,151 | 591.48 | 638.99 | 670.21 |
Net Cash (Debt) | -4.54 | -191.84 | -352.22 | -243.44 | -331.82 | -648.02 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.01 | -0.48 | -1.03 | -0.88 | -1.33 | -8.98 |
Filing Date Shares Outstanding | 400 | 400 | 400 | 328.57 | 249.73 | 249.73 |
Total Common Shares Outstanding | 400 | 400 | 400 | 328.57 | 249.73 | 249.73 |
Working Capital | 940.36 | 852.2 | 384.21 | 428.98 | 126.89 | -280.97 |
Book Value Per Share | 5.58 | 5.29 | 4.42 | 4.62 | 4.17 | 2.29 |
Tangible Book Value | 2,183 | 2,072 | 1,736 | 1,494 | 1,030 | 570.91 |
Tangible Book Value Per Share | 5.46 | 5.18 | 4.34 | 4.55 | 4.12 | 2.29 |
Land | - | 124.07 | 124.07 | 108.09 | 94.16 | 64.95 |
Buildings | - | 1,166 | 1,104 | 1,014 | 897.56 | 713.66 |
Machinery | - | 597.82 | 610.1 | 548.56 | 448.73 | 415.39 |
Construction In Progress | - | 84.1 | 81.02 | 68.6 | 93.44 | 82.16 |